US Stocks prediction

Ah, indeed! A question I am inclined to ponder deeply, yet the answer seems as elusive as a whisper in the wind-next inquiry, if you please.

IonQ dares to dream-a lofty aspiration to become the Nvidia of quantum computing. It aspires to craft the very devices that shall propel us into a new age, akin to the pivotal role Nvidia plays in the current technological paradigm. Yet, herein lies the tension: if IonQ succeeds, the stock could indeed reach vertiginous heights. But are we toys of fate, pondering if now is the moment to cast our fortunes to a capricious tide?

First, the *”good”* news (though “good” here might need quotation marks, as all good news in the stock market comes with a footnote). Eli Lilly, ever the savvy merchant of hope and profit, has decided to expand the Mounjaro GLP-1 weight loss drug business into India. A noble venture, no doubt-selling injector pens loaded with the weight loss elixir at the remarkably *modest* price of $160 for a 2.5 mg dose. (Of course, should you need a little more of this wonder drug, that price scales up-oh, yes, it does-up to $315 for the 15 mg dose. Don’t ask how much it costs to *lose* the weight of your soul in the process.)

What, you may ask, caused this peculiar oscillation? Ah, dear reader, the answer lies not merely in numbers but in the intricate ballet of expectation and reality-a performance for which markets are renowned connoisseurs.

Behold! Since August 2022, Palantir’s stock has gone from “meh” to “mind-blowing 1,500% surge.” A $10k bet back then? Now it’s $160k. Impressive, yes? But let’s not confuse velocity for wisdom. Imagine a scribe in 1200 AD, scribbling, “This goose just laid a golden egg… and another… and another!” Then, one day, the goose says, “Actually, I’m a goose. Stop expecting diamonds.” Palantir’s market cap? Now $440 billion. That’s 36 castles’ worth of gold. But remember, even dragons get tired of breathing fire.

Now, let me pause here for a moment to marvel at how strange it is that markets can behave like moody teenagers-capable of sulking over imagined slights while ignoring perfectly good news. In this case, Global-e managed to grow revenue by 28%, turned a profit for the second time in three quarters, and even raised its full-year sales growth guidance to 31%. If I were grading companies like students, I’d give them an A-minus for effort. And yet, the market seems determined to flunk them anyway.

Disappointment disguised itself as a fickle friend when CoreWeave unveiled its second-quarter results for 2025 only yesterday, unveiling a juxtaposition of triumph and disillusionment. As the clock struck 9:45 a.m. ET, the weight of discontent bore down upon the stock, driving it to a retreat of 13.8%. A foreboding whisper circulated among the investors, echoing the seductive call to relinquish their holdings.

Earlier in the month, the electric vehicle (EV) manufacturer, a peculiar beast hailing from the vast land of China, reported a growth of 17.5% in deliveries year-over-year for the month of June. But it was not merely the numbers that caused such a stir; no, it was the company’s recent attempts at expansion-through the launch of Firefly and Onvo-that piqued the interest of the masses. These new sub-brands, together, contributed a noteworthy 40% to Nio’s June sales. What an odd spectacle this is, a company previously known for its somewhat quiet existence now creating waves that could almost drown a small village.

The company, which supplies low-enriched uranium to nuclear power plants, just announced it’s raising $650 million via convertible senior notes to fund a HALEU (high-assay, low-enriched uranium) business. Because nothing says “confidence” like printing money to build a business… for reactors. Classic corporate cocktail: debt + dilution + a side of “we’re totally not panicking.”

The investment wasn’t just a whim; it represented 0.88% of iA Global’s 13F assets under management (AUM), which sounds modest until you realize how many zeros are involved. After this transaction, the fund now holds 421,023 shares of Danaher, worth roughly $83.17 million. To put that into perspective, Danaher accounts for 1.25% of the fund’s reportable assets across 416 positions. It’s almost touching, really, how much effort goes into dividing up percentages like leftover pie slices.